- TransMedics Reports First Quarter 2024 Financial Results
- TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- TransMedics to Present at Upcoming March Investor Conferences
- TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results
- TransMedics to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 126.20 |
---|---|
High | 127.70 |
Low | 123.62 |
Bid | 125.71 |
Offer | 125.97 |
Previous close | 127.28 |
Average volume | 1.50m |
---|---|
Shares outstanding | 32.94m |
Free float | 31.86m |
P/E (TTM) | -- |
Market cap | 4.19bn USD |
EPS (TTM) | -0.335 USD |
Data delayed at least 15 minutes, as of May 08 2024 18:29 BST.
More ▼